Ipsen Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
57 result(s) found, displaying 41 to 50
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Cabozantinib
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
Prescription medicine registrationActive ingredients: telotristat etiprate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 125 Ipsen Units powder for injection vial.
-
-
Prescription medicine registrationActive ingredients: Clostridium botulinum type a toxin haemagglutinin complex.
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
Cancellation for failure to pay annual chargeCancelled under 30(2)(f) of the Act
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DYSPORT clostridium botulinum type A toxin - haemagglutinin complex 300 Ipsen Units powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DIPHERELINE triptorelin (as embonate) 22.5 mg powder for suspension vial and water for injections ampoule.